Updated:
Farmak
Farmak is a Ukrainian pharmaceutical manufacturer and a leader in the domestic market since 2010. The company produces a wide range of prescription drugs, OTC...
Farmak
Farmak is a Ukrainian pharmaceutical manufacturer and a leader in the domestic market since 2010. The company produces a wide range of prescription drugs, OTC medicines, medical devices, and dietary supplements, exporting to over 60 countries. It operates two plants in Ukraine and has a full production cycle from API synthesis to finished dosage forms, with an R&D complex of 12 laboratories developing around 20 new drugs annually.
General information
Firm type
other
Location
Region
Europe
Country
Ukraine
City
Kyiv
Corporate office
Kyiv, Ukraine
Additional offices
Baar, Switzerland · Tashkent, Uzbekistan · Almaty, Kazakhstan · Bishkek, Kyrgyzstan · Chișinău, Moldova · Dubai, United Arab Emirates · Ho Chi Minh City, Vietnam · Warsaw, Poland · Bratislava, Slovakia · Prague, Czech Republic · Hull, United Kingdom · Barcelona, Spain
Sector focus
Frequently asked questions
Who owns Farmak?
Farmak is a private Ukrainian pharmaceutical company. The Zhebrivsky family is associated with the company through the Zhebrivsky Family Charitable Foundation, but public ownership details and the wealth origin of the family are not disclosed.
Is Farmak structured as a family office?
No. Farmak is an operating pharmaceutical manufacturer, not a family office. It does not manage third-party capital or make external investment allocations. The Zhebrivsky family maintains a separate charitable foundation for philanthropic activities.
What investment stages or asset classes does Farmak participate in?
Farmak is not an investment firm. It operates exclusively in pharmaceutical manufacturing, R&D, and distribution. Its capital deployment is internal: reinvesting up to 90% of profit into production capacity, R&D, and regulatory compliance (per the firm's website).
What markets does Farmak serve?
Farmak leads the Ukrainian pharmaceutical market by sales volume and exports to over 50 countries. Key regions include Europe (Poland, Slovakia, Czech Republic, UK, Spain, Switzerland), Central Asia (Kazakhstan, Uzbekistan, Kyrgyzstan), the Middle East (UAE), and Southeast Asia (Vietnam), with additional offices in Moldova (per the firm, 2025).
What is the Zhebrivsky Family Charitable Foundation?
The Zhebrivsky Family Charitable Foundation is a separate philanthropic entity associated with the owners of Farmak. It conducts social and military support activities, such as donating medicines for Ukrainian soldiers. The foundation is operationally independent from the manufacturing business.
What regulatory certifications does Farmak hold?
Farmak's production facilities and labs hold European GMP certifications and have passed nearly 100 national and foreign inspections from partners in the UK, Switzerland, Germany, and other countries. Its quality control laboratories are accredited for 144 testing methods listed in the Ukrainian, European, British, and US Pharmacopoeias.
Does Farmak have any known relationship with external family offices or allocators?
No publicly available information suggests any relationship with external family offices, institutional allocators, or third-party capital vehicles. The company operates as a private, self-funded pharmaceutical manufacturer.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: